Best of the Week
Most Popular
1. Stock Markets and the History Chart of the End of the World (With Presidential Cycles) - 28th Aug 20
2.Google, Apple, Amazon, Facebook... AI Tech Stocks Buying Levels and Valuations Q3 2020 - 31st Aug 20
3.The Inflation Mega-trend is Going Hyper! - 11th Sep 20
4.Is this the End of Capitalism? - 13th Sep 20
5.What's Driving Gold, Silver and What's Next? - 3rd Sep 20
6.QE4EVER! - 9th Sep 20
7.Gold Price Trend Forecast Analysis - Part1 - 7th Sep 20
8.The Fed May “Cause” The Next Stock Market Crash - 3rd Sep 20
9.Bitcoin Price Crash - You Will be Suprised What Happens Next - 7th Sep 20
10.NVIDIA Stock Price Soars on RTX 3000 Cornering the GPU Market for next 2 years! - 3rd Sep 20
Last 7 days
Still More Room To Stock Market Downside In The Coming Weeks - 23rd Sep 20
Platinum And Palladium Set To Surge As Gold Breaks Higher - 23rd Sep 20
Key Gold Ratios to Other Markets - 23rd Sep 20
Watch Before Upgrading / Buying RTX 3000, RDNA2 - CPU vs GPU Bottlenecks - 23rd Sep 20
Online Elliott Wave Markets Trading Course Worth $129 for FREE! - 22nd Sep 20
Gold Price Overboughtness Risk - 22nd Sep 20
Central Banking Cartel Promises ZIRP Until at Least 2023 - 22nd Sep 20
Stock Market Correction Approaching Initial Objective - 22nd Sep 20
Silver Bulls Will Be Handsomely Rewarded - 21st Sep 20
Fed Will Not Hike Rates For Years. Gold Should Like It - 21st Sep 20
US Financial Market Forecasts and Elliott Wave Analysis Resources - 21st Sep 20
How to Avoid Currency Exchange Risk during COVID - 21st Sep 20
Crude Oil – A Slight Move Higher Has Not Reversed The Bearish Trend - 20th Sep 20
Do This Instead Of Trying To Find The “Next Amazon” - 20th Sep 20
5 Significant Benefits of the MT4 Trading Platform for Forex Traders - 20th Sep 20
A Warning of Economic Collapse - 20th Sep 20
The Connection Between Stocks and the Economy is not What Most Investors Think - 19th Sep 20
A Virus So Deadly, The Government Has to Test You to See If You Have It - 19th Sep 20
Will Lagarde and Mnuchin Push Gold Higher? - 19th Sep 20
RTX 3080 Mania, Ebay Scalpers Crazy Prices £62,000 Trollers Insane Bids for a £649 GPU! - 19th Sep 20
A Greater Economic Depression For The 21st Century - 19th Sep 20
The United Floor in Stocks - 19th Sep 20
Mobile Gaming Market Trends And The Expected Future Developments - 19th Sep 20
The S&P 500 appears ready to correct, and that is a good thing - 18th Sep 20
It’s Go Time for Gold Price! Next Stop $2,250 - 18th Sep 20
Forget AMD RDNA2 and Buy Nvidia RTX 3080 FE GPU's NOW Before Price - 18th Sep 20
Best Back to School / University Black Face Masks Quick and Easy from Amazon - 18th Sep 20
3 Types of Loans to Buy an Existing Business - 18th Sep 20
How to tell Budgie Gender, Male or Female Sex for Young and Mature Parakeets - 18th Sep 20
Fasten Your Seatbelts Stock Market Make Or Break – Big Trends Ahead - 17th Sep 20
Peak Financialism And Post-Capitalist Economics - 17th Sep 20
Challenges of Working from Home - 17th Sep 20
Sheffield Heading for Coronavirus Lockdown as Covid Deaths Pass 432 - 17th Sep 20
What Does this Valuable Gold Miners Indicator Say Now? - 16th Sep 20
President Trump and Crimes Against Humanity - 16th Sep 20
Slow Economic Recovery from CoronaVirus Unlikely to Impede Strong Demand for Metals - 16th Sep 20
Why the Knives Are Out for Trump’s Fed Critic Judy Shelton - 16th Sep 20
Operation Moonshot: Get Ready for Millions of New COVAIDS Positives in the UK! - 16th Sep 20
Stock Market Approaching Correction Objective - 15th Sep 20
Look at This Big Reminder of Dot.com Stock Market Mania - 15th Sep 20
Three Key Principles for Successful Disruption Investors - 15th Sep 20
Billionaire Hedge Fund Manager Warns of 10% Inflation - 15th Sep 20
Gold Price Reaches $2,000 Amid Dollar Depreciation - 15th Sep 20
GLD, IAU Big Gold ETF Buying MIA - 14th Sep 20
Why Bill Gates Is Betting Millions on Synthetic Biology - 14th Sep 20
Stock Market SPY Expectations For The Rest Of September - 14th Sep 20
Gold Price Gann Angle Update - 14th Sep 20
Stock Market Recovery from the Sharp Correction Goes On - 14th Sep 20
Is this the End of Capitalism? - 13th Sep 20
The Silver Big Prize - 13th Sep 20
U.S. Shares Plunged. Is Gold Next? - 13th Sep 20
Why Are 7,500 Oil Barrels Floating on this London Lake? - 13th Sep 20
Sheffield 432 Covid-19 Deaths, Last City Centre Shop Before Next Lockdown - 13th Sep 20
Biden or Trump Will Keep The Money Spigots Open - 13th Sep 20
Gold And Silver Up, Down, Sideways, Up - 13th Sep 20

Market Oracle FREE Newsletter

How to Get Rich Investing in Stocks by Riding the Electron Wave

Profit From Tech That Freezes Fat Away

Companies / Healthcare Sector Nov 13, 2014 - 05:35 PM GMT

By: Money_Morning

Companies

Michael A. Robinson writes: Five years ago, I quit drinking.

I did so not because I had a problem, but in order to shed some weight. And I was lucky – after I stopped drinking, the pounds just seemed to melt away.

I know most folks aren't that fortunate. That's why dieting and exercise in the United States is a $60.5 billion industry.


The party season surrounding Thanksgiving, Christmas, and New Year's is rapidly approaching, and so that weight-watching industry is just as quickly ramping up its marketing.

With that in mind, I found us a way to invest in this huge sector – and also stick with our mission to build wealth through technology.

And this company is in turnaround – setting us up with a "special situation" stock with the potential to double in three years…

Welcome to the New "Aesthetic Medicine"

Please – don't think I'm suggesting you invest in some new diet fad. Far from it.

The technology I want to tell you about involves a breakthrough medical device approved by the U.S. Food and Drug Administration, an agency that is always on the lookout for scams.

In fact, the company I have in mind successfully treated more than 4,000 patients during clinical trials.

It also has published more than 40 medical papers and abstracts on its science, which was developed at a teaching hospital affiliated with Harvard Medical School.

And besides the tens of billions of dollars we spend on weight loss each year, there's another number that demonstrates how large this company's market could eventually be.

According to the American Medical Association, more than 75 million Americans are obese. The condition causes a wide range of problems that can lead to premature death, including heart disease or diabetes.

And in addition to the obese, millions more of us are in pretty good shape but would just like to drop a few unsightly pounds. I know from experience that it's hard to get rid of love handles. For women, it's often the hips or thighs that bedevil them.

These are the kinds of cases tailor-made for what's known as "aesthetic medicine," a field that includes everything from plastic surgery to liposuction.

Forecasters at BCC Research estimate that aesthetic medicine is growing at an annual compound rate of 7.4% and should hit $4.8 billion by the end of next year.

Clearly, ZELTIQ Aesthetics Inc. (Nasdaq: ZLTQ) and other aesthetic medicine firms have a great opportunity to do well now and in the future. This growing medical tech firm uses controlled cooling to eliminate unwanted body fat in a nonsurgical, minimally invasive procedure known as Cryolipolysis.

How This New Tech Freezes Fat Away

That's a mouthful. So let me tell you about it.

Simply stated, ZELTIQ freezes away the fat. The company uses a cooling device to destroy fat cells. The device extracts energy from those cells without damaging other tissue.

Cryolipolysis also has no effect on a patient's skin, which means minimal recovery time and no sign of treatment.

Over the course of two to four months, the fat cells in the treated areas are gradually eliminated through the body's normal metabolic processes.

ZELTIQ's CoolSculpting system consists of a control unit and a number of applicators. ZELTIQ derives most of its revenue from sales of the CoolSculpting system and of the applicators doctors use to treat different sizes and shapes of fat bulges.

Additional sales stem from something the firm calls "cycles." These are specific-use procedure packs activated with the CoolSculpting machine. A cycle lasts about an hour, and patients typically need two "cycles" to treat for the arms and up to four to treat stomach fat.

If it executes against its plan, ZELTIQ will see a lot of growth. Based on U.S. Census data and its own consumer surveys, the company says it could hit $2 billion in sales over the next few years. In 2013, ZELTIQ had sales of $111.6 million.

ZELTIQ arrived at that $2 billion number after its surveys projected some 4 million Americans would be ready to receive treatment that would require four cycles at $125 each.

Going public in 2010 amid great excitement about its unique technology in a huge market, the company quickly stumbled. It racked up several quarters of losses, putting the stock under pressure.

To capitalize on its potential, ZELTIQ needed a strong corporate turnaround. And that's just what started happening in 2012 when the board of directors shook up the management team.
A Company Firmly in Turnaround

This is the pivotal event in the company's recent history. I've been involved with turnarounds since the early 1980s, and so I know that most of the successful ones require a new visionary leader who surrounds him- or herself with a talented team.

Mark Foley became president and chief executive officer of ZELTIQ in April 2012. He has more than 25 years of experience in the medical device industry, having served as an executive at several fast-growing startups later acquired by global firms.

In fall 2012, Foley brought in new managers to serve as chief technology officer, chief financial officer, head of worldwide sales and marketing, and vice president of operations.

Those appointments hailed from such medical tech leaders as NuVasive Inc. (Nasdaq: NUVA), Medtronic Inc. (NYSE: MDT), and Thoratec Corp. (Nasdaq: THOR).

Foley also split ZELTIQ's sales team in two. One sells the CoolSculpting equipment, and the other focuses on selling the supplies. ZELTIQ also holds teaching clinics for aesthetic medicine professionals so they give patients the best results – and lead to more referrals.

It's all starting to pay off.

In this year's third quarter, ZELTIQ smashed Wall Street's expectations. ZELTIQ was projected to lose $0.10 a share but actually earned $0.12. Sales climbed 55% to $45.7 million – more than 15% above analysts' forecasts.

With a market cap of roughly $1 billion, the stock trades at about $27.75. Profit margins and returns on equity remain weak, underscoring that this is a turnaround in progress.

But on the strength of its new strategic plan and recent profits, ZELTIQ is in a rally. It's up 50% in the past three months and is trading near a new high.

Yet, I still see plenty of upside ahead for this "special situation." If the company continues growing sales and earnings at anything close to its current rate, the stock could easily double in the next three years.

Of course, special situations like this belong in the higher risk portion of your portfolio.

But it doesn't take many stocks like ZELTIQ to really boost your net worth.

And during the holiday season, we could all use a little more worth in our pockets.

Source : http://moneymorning.com/2014/11/13/this-profit-doubling-companys-product-freezes-fat-away/

Money Morning/The Money Map Report

©2014 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email: customerservice@moneymorning.com

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Money Morning Archive

© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules